BLB&B Advisors’s Labcorp LH Stock Holding History

BLB&B Advisors’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-771	Closed	-$221K	–	283
2025 Q3	$221K	Hold	771	–	–	0.01%	260
2025 Q2	$202K	Buy	+771	New	+$188K	0.01%	265
2023 Q3	–	Sell	-1,008	Closed	-$209K	–	250
2023 Q2	$209K	Buy	+1,008	New	+$196K	0.01%	235

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BLB&B Advisors's LH Position: Q4 2025 in Review

BLB&B Advisors sold out of Labcorp (LH) in Q4 2025, closing a stake of 771 shares — an estimated $221K sold.

BLB&B Advisors first reported a position in LH in Q2 2023 and held it in 3 quarters. The position peaked at $221K in Q3 2025. 1,027 funds tracked by Wall St. Rank hold LH as of Q4 2025.

BLB&B Advisors reported no remaining Labcorp position as of Q4 2025 after selling out during the quarter.
BLB&B Advisors sold 771 Labcorp shares in Q4 2025, an estimated $221K.
BLB&B Advisors first reported a position in Labcorp in Q2 2023 and held it in 3 quarters.
BLB&B Advisors's Labcorp position peaked at $221K in Q3 2025.
1,027 funds tracked by Wall St. Rank held Labcorp as of Q4 2025.

Based on BLB&B Advisors's 13F filing for Q4 2025, filed 26 Jan 2026.